BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 23525716)

  • 1. PET/MR imaging: technical aspects and potential clinical applications.
    Torigian DA; Zaidi H; Kwee TC; Saboury B; Udupa JK; Cho ZH; Alavi A
    Radiology; 2013 Apr; 267(1):26-44. PubMed ID: 23525716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated PET/MR.
    Quick HH
    J Magn Reson Imaging; 2014 Feb; 39(2):243-58. PubMed ID: 24338921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy.
    Runge VM
    Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience of MR/PET in a clinical cancer center.
    Partovi S; Robbin MR; Steinbach OC; Kohan A; Rubbert C; Vercher-Conejero JL; Kolthammer JA; Faulhaber P; Paspulati RM; Ros PR
    J Magn Reson Imaging; 2014 Apr; 39(4):768-80. PubMed ID: 24006287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and performance evaluation of simultaneous PET/MR whole-body imaging with continuous table motion.
    Braun H; Ziegler S; Lentschig MG; Quick HH
    J Nucl Med; 2014 Jan; 55(1):161-8. PubMed ID: 24232869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal imaging approaches: PET/CT and PET/MRI.
    Pichler BJ; Judenhofer MS; Pfannenberg C
    Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/MRI: challenges, solutions and perspectives.
    Herzog H
    Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of flexible body surface coil and patient table on PET quantification and image quality in integrated PET/MR.
    Fürst S; Souvatzoglou M; Martinez-Möller A; Schwaiger M; Nekolla SG; Ziegler SI
    Nuklearmedizin; 2014; 53(3):79-87. PubMed ID: 24658368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current image acquisition options in PET/MR.
    Boellaard R; Quick HH
    Semin Nucl Med; 2015 May; 45(3):192-200. PubMed ID: 25841274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
    Rakheja R; Chandarana H; Ponzo F; Seltzer AL; Beltran LS; Geppert C; Friedman KP
    PET Clin; 2014 Apr; 9(2):237-52. PubMed ID: 25030285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
    Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
    Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques, benefits, and challenges of PET-MR.
    Ocampo T; Knight K; Dunleavy R; Shah SN
    Radiol Technol; 2015; 86(4):393-412; quiz 413-6. PubMed ID: 25835405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical positron emission tomography/magnetic resonance imaging applications.
    von Schulthess GK; Kuhn FP; Kaufmann P; Veit-Haibach P
    Semin Nucl Med; 2013 Jan; 43(1):3-10. PubMed ID: 23178084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards improved hardware component attenuation correction in PET/MR hybrid imaging.
    Paulus DH; Tellmann L; Quick HH
    Phys Med Biol; 2013 Nov; 58(22):8021-40. PubMed ID: 24168832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
    Navalpakkam BK; Braun H; Kuwert T; Quick HH
    Invest Radiol; 2013 May; 48(5):323-32. PubMed ID: 23442772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
    Luboldt W; Küfer R; Blumstein N; Toussaint TL; Kluge A; Seemann MD; Luboldt HJ
    Radiology; 2008 Dec; 249(3):1017-25. PubMed ID: 18849502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.